Talk:Rifaximin

This is the talk page for discussing improvements to the Rifaximin article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Rifaximin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

i've the full clinical insert for this and have taken it myself -- Lieutenant Colonel Frank Slade 09:51, 2 July 2006 (UTC)[reply]

one of the most complex molecular structures i've ever seen in my life, too =) -- Lieutenant Colonel Frank Slade 09:55, 2 July 2006 (UTC)[reply]

mostly prescribed with people w/ ibs strictly for abdomninal pain -- although there have been trials to help the diarrhea, they've been mostly inconclusive. there is currently a crohn's colitis test going on with higher doses which looks much more promising (~1200mg/day) -- Lieutenant Colonel Frank Slade 11:43, 2 July 2006 (UTC)[reply]

Dead link

The link to the label information is broken. The correct link is this. Could someone with edit rights fix it? 81.99.218.67 (talk) 10:44, 19 March 2011 (UTC)[reply]

Approval in Canada

According to this link, this drug (under the trade name "Zaxine") has been approved for use in Canada as of October, 2013, and has been assigned a DIN as well:

http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/drug-med/sbd_smd_2013_zaxine_161256-eng.php

Should the article be updated to reflect this? — Preceding unsigned comment added by EishethIntegra (talk • contribs) 05:09, 18 March 2014 (UTC)[reply]

Generic absorption differences

Article in question is not the direct source. Direct source indicates conflict of interest between researchers and Alfa Wassermann, the company that holds the patent. https://doi.org/10.1016/j.phrs.2014.05.001 — Preceding unsigned comment added by WereJesus (talk • contribs) 01:26, 4 April 2022 (UTC)[reply]

It is very expensive

My doctor presribed me this for irritable bowel. Because he is a GP and not a specialist, I have to pay full price, which is like AUD $500 for a 3 week course. 2001:8003:E490:7D01:89E1:A5F5:4162:44A2 (talk) 02:23, 23 June 2023 (UTC)[reply]